Compare Aurobindo Pharma with COMBAT DRUGS - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs COMBAT DRUGS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA COMBAT DRUGS AUROBINDO PHARMA/
COMBAT DRUGS
 
P/E (TTM) x 9.9 26.5 37.3% View Chart
P/BV x 3.2 3.0 105.0% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AUROBINDO PHARMA   COMBAT DRUGS
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-20
COMBAT DRUGS
Mar-20
AUROBINDO PHARMA/
COMBAT DRUGS
5-Yr Chart
Click to enlarge
High Rs83834 2,453.9%   
Low Rs28116 1,735.5%   
Sales per share (Unadj.) Rs394.223.7 1,660.0%  
Earnings per share (Unadj.) Rs48.51.1 4,453.7%  
Cash flow per share (Unadj.) Rs65.01.6 3,964.9%  
Dividends per share (Unadj.) Rs3.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs286.912.4 2,306.9%  
Shares outstanding (eoy) m585.9310.10 5,801.3%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x1.41.1 133.9%   
Avg P/E ratio x11.523.1 49.9%  
P/CF ratio (eoy) x8.615.3 56.1%  
Price / Book Value ratio x2.02.0 96.3%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m327,872254 128,947.7%   
No. of employees `000NANA-   
Total wages/salary Rs m32,192196 16,465.6%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m230,985240 96,300.0%  
Other income Rs m1,9193 70,282.1%   
Total revenues Rs m232,904243 96,007.2%   
Gross profit Rs m48,38225 191,763.0%  
Depreciation Rs m9,6676 173,868.7%   
Interest Rs m3,0518 39,473.5%   
Profit before tax Rs m37,58215 256,358.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m9,1354 250,279.5%   
Profit after tax Rs m28,44711 258,373.3%  
Gross profit margin %20.910.5 199.2%  
Effective tax rate %24.324.9 97.6%   
Net profit margin %12.34.6 268.3%  
BALANCE SHEET DATA
Current assets Rs m164,125244 67,396.9%   
Current liabilities Rs m113,868230 49,471.0%   
Net working cap to sales %21.85.6 391.1%  
Current ratio x1.41.1 136.2%  
Inventory Days Days15117 13.1%  
Debtors Days Days68222 30.7%  
Net fixed assets Rs m123,507127 97,564.2%   
Share capital Rs m586101 580.1%   
"Free" reserves Rs m167,51825 680,690.4%   
Net worth Rs m168,104126 133,829.9%   
Long term debt Rs m00-   
Total assets Rs m287,632370 77,717.2%  
Interest coverage x13.32.9 459.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.80.6 123.9%   
Return on assets %11.05.1 216.2%  
Return on equity %16.98.8 193.1%  
Return on capital %24.217.8 135.6%  
Exports to sales %46.40-   
Imports to sales %15.10-   
Exports (fob) Rs m107,126NA-   
Imports (cif) Rs m34,902NA-   
Fx inflow Rs m107,4450-   
Fx outflow Rs m38,9910-   
Net fx Rs m68,4540-   
CASH FLOW
From Operations Rs m43,813-152 -28,862.2%  
From Investments Rs m-15,676-1 1,274,504.1%  
From Financial Activity Rs m-19,472180 -10,796.7%  
Net Cashflow Rs m8,71228 30,645.1%  

Share Holding

Indian Promoters % 48.8 0.0 -  
Foreign collaborators % 3.1 45.9 6.7%  
Indian inst/Mut Fund % 38.4 0.0 -  
FIIs % 23.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 54.1 89.1%  
Shareholders   243,315 12,634 1,925.9%  
Pledged promoter(s) holding % 22.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   BHARAT PARENTALS  AMBALAL SARABHAI  S.S.ORGANICS  DECCAN HEALTH CARE  AMRUTANJAN HEALTHCARE  



Today's Market

Sensex Ends 123 Points Higher; Bharti Airtel and Eicher Motors Among Top Nifty Gainers(Closing)

Indian share markets witnessed volatile trading activity throughout the day today and ended higher.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (1QFY21); Net Profit Up 25.6% (Quarterly Result Update)

Sep 15, 2020 | Updated on Sep 15, 2020

For the quarter ended June 2020, AUROBINDO PHARMA has posted a net profit of Rs 8 bn (up 25.6% YoY). Sales on the other hand came in at Rs 59 bn (up 8.8% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (4QFY20); Net Profit Up 48.2% (Quarterly Result Update)

Jun 5, 2020 | Updated on Jun 5, 2020

For the quarter ended March 2020, AUROBINDO PHARMA has posted a net profit of Rs 9 bn (up 48.2% YoY). Sales on the other hand came in at Rs 62 bn (up 16.4% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 0.5% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (down 0.5% YoY). Sales on the other hand came in at Rs 58 bn (up 10.1% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (2QFY20); Net Profit Up 4.6% (Quarterly Result Update)

Nov 15, 2019 | Updated on Nov 15, 2019

For the quarter ended September 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 4.6% YoY). Sales on the other hand came in at Rs 56 bn (up 17.9% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

AUROBINDO PHARMA 2018-19 Annual Report Analysis (Annual Result Update)

Nov 6, 2019 | Updated on Nov 6, 2019

Here's an analysis of the annual report of AUROBINDO PHARMA for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

These Stocks Are Ready to Zoom(Fast Profits Daily)

Aug 3, 2021

These stocks are the best from a traders point of view.

A Trading Hack to Multiply Profits(Fast Profits Daily)

Jul 23, 2021

Use this trading hack and get a big boost in your trading profits.

How to Pick Momentum Stocks(Fast Profits Daily)

Jul 26, 2021

Use my trading momentum strategy to increase your trading profits.

Devyani International IPO: Key Points to Consider(Views On News)

Jul 31, 2021

Its raining IPOs as 4 public issues open next week on the same day. Which one will you subscribe to?

A Rare Opportunity for Long-Term Investors Amid the Rout in China's Tech Stocks(Profit Hunter)

Jul 29, 2021

The epicentre of a tech-bubble led market crash in 2021 is closer than you think.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

AUROBINDO PHARMA SHARE PRICE


Aug 5, 2021 (Close)

TRACK AUROBINDO PHARMA

  • Track your investment in AUROBINDO PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON AUROBINDO PHARMA

AUROBINDO PHARMA 8-QTR ANALYSIS

COMPARE AUROBINDO PHARMA WITH

MARKET STATS